These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1659876)

  • 1. Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities.
    Armanini D; Wehling M; Da Dalt L; Zennaro M; Scali U; Keller U; Pratesi C; Mantero F; Kuhnle U
    J Steroid Biochem Mol Biol; 1991; 40(1-3):363-5. PubMed ID: 1659876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects.
    Kuhnle U; Nielsen MD; Tietze HU; Schroeter CH; Schlamp D; Bosson D; Knorr D; Armanini D
    J Clin Endocrinol Metab; 1990 Mar; 70(3):638-41. PubMed ID: 2137831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronism.
    Wehling M; Kuhnle U; Daumer C; Armanini D
    Clin Endocrinol (Oxf); 1989 Nov; 31(5):597-605. PubMed ID: 2627754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
    Kuhnle U; Hinkel GK; Hubl W; Reichelt T
    Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence of mineralocorticoid receptors in peripheral lymphocytes: presence of receptor-like activity in patients with the autosomal dominant form of pseudohypoaldosteronism, and its absence in the recessive form.
    Kuhnle U; Keller U; Armanini D; Funder J; Krozowski Z
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):267-73. PubMed ID: 7826888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency.
    Bosson D; Kuhnle U; Mees N; Ramet J; Vamos E; Vertongen F; Wolter R; Armanini D
    Acta Endocrinol Suppl (Copenh); 1986; 279():376-80. PubMed ID: 2946135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
    Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
    J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Receptor-effector relations in the effect of adosterone on mononuclear leukocytes: validation and application to various water and electrolyte imbalances in humans].
    Wehling M
    Klin Wochenschr; 1989 Jan; 67(1):1-5. PubMed ID: 2537910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial pseudohypoaldosteronism: a review on the heterogeneity of the syndrome.
    Kuhnle U; Hinkel GK; Akkurt HI; Krozowski Z
    Steroids; 1995 Jan; 60(1):157-60. PubMed ID: 7792804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determination of mineralocorticoid receptors in human mononuclear leukocytes from patients with mineralocorticoid excess: physiological and pathological implications.
    Armanini D; Kuhnle U; Witzgall H; Tietze U; Saule H; Schroeter C; Strasser T; Butenandt I; Bidlingmaier F; Weber PC
    Clin Exp Hypertens A; 1986; 8(4-5):781-5. PubMed ID: 3019593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion of the locus for autosomal recessive pseudohypoaldosteronism type 1 from the mineralocorticoid receptor gene region on human chromosome 4q by linkage analysis.
    Chung E; Hanukoglu A; Rees M; Thompson R; Dillon M; Hanukoglu I; Bistritzer T; Kuhnle U; Seckl J; Gardiner RM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3341-5. PubMed ID: 7593448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
    Zennaro MC; Fernandes-Rosa F
    J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
    Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
    Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Soubrier F
    J Clin Endocrinol Metab; 1994 Jul; 79(1):32-8. PubMed ID: 8027248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.